Search Ontology:
ChEBI
AZ505
- Term ID
- CHEBI:228259
- Synonyms
-
- AZ 505
- AZ-505
- N-cyclohexyl-3-[2-(3,4-dichlorophenyl)ethylamino]-N-[2-[2-(5-hydroxy-3-oxo-4H-1,4-benzoxazin-8-yl)ethylamino]ethyl]propanamide
- N-cyclohexyl-N(3)-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[2-(5-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-beta-alaninamide
- Definition
- A benzoxazine that is 2H-1,4-benzoxazin-3(4H)-one substituted by a hydroxy group at position 5 and a 2-{[2-(cyclohexyl{N-[2-(3,4-dichlorophenyl)ethyl]-β-alanyl}amino)ethyl]amino}ethyl group at position 8. It is a potent and selective inhibitor of SMYD2.
- References
-
- cas:1035227-43-0
- pubmed:21782458
- pubmed:25834495
- pubmed:28588028
- pubmed:28604386
- pubmed:29487338
- pubmed:31754403
- pubmed:32277055
- pubmed:33935284
- pubmed:34143514
- pubmed:34510321
- pubmed:34905676
- pubmed:35455942
- pubmed:35759739
- pubmed:35939202
- pubmed:36046818
- pubmed:37036190
- pubmed:37315132
- pubmed:37524453
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from AZ505
Phenotype where environments contain AZ505
Phenotype modified by environments containing AZ505
Phenotype affecting AZ505
Human Disease Model